LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 320419

Suchoptionen

  1. Buch: Huan zhe dao de quan li bao hu yu he xie yi huan guan xi jian gou

    Wang, Xiaobo

    The protection of patients' moral rights & the building of harmonious doctor-patient relationship

    2015  

    Titelvarianten Protection of patients' moral rights & the building of harmonious doctor-patient relationship
    Verfasserangabe Wang Xiaobo zhu
    Mesh-Begriff(e) Patient Rights ; Physician-Patient Relations
    Schlagwörter China
    Sprache Chinesisch
    Umfang 2, 4, 248 pages
    Ausgabenhinweis Di 1 ban.
    Dokumenttyp Buch
    ISBN 9787010151342 ; 7010151342
    Datenquelle Katalog der US National Library of Medicine (NLM)

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Reply to the Letter to the Editor of Y. Zhao, et al. concerning "Association between IGF1 gene single nucleotide polymorphism (rs5742612) and adolescent idiopathic scoliosis: a meta-analysis" by Ming Guan, Huan Wang et al. Eur Spine J (2016). doi:10.1007/s00586-016-4742-7.

    Guan, Ming / Wang, Huan / Fang, Huang

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

    2017  Band 26, Heft 4, Seite(n) 1314–1315

    Sprache Englisch
    Erscheinungsdatum 2017-04
    Erscheinungsland Germany
    Dokumenttyp Letter
    ZDB-ID 1115375-1
    ISSN 1432-0932 ; 0940-6719
    ISSN (online) 1432-0932
    ISSN 0940-6719
    DOI 10.1007/s00586-017-5007-9
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Bu Yang Huan Wu decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1 α, VEGF and promotion β-ENaC expression.

    Chen, Zhen-Zhen / Gong, Xin / Guo, Qi / Zhao, Hui / Wang, Lei

    Journal of ethnopharmacology

    2018  Band 228, Seite(n) 70–81

    Abstract: Ethnopharmacological relevance: Bu Yang Huan Wu Decoction (BYHW) is a famous ...

    Abstract Ethnopharmacological relevance: Bu Yang Huan Wu Decoction (BYHW) is a famous traditional Chinese medicine (TCM) formula used in China for the treatment of cerebral ischemic stroke. But the protective effects and underlining mechanisms of BYHW remain unclear.
    Aim of the study: This study was designed to investigate the protective effects and underlining signaling mechanisms of BYHW on brain tissues in a rat model of cerebral ischemic reperfusion (I/R) injury.
    Materials and methods: Liquid chromatography was used to verify the composition of BYHW. The cerebral edema and infarct volume were measured by magnetic resonance imaging (MRI). The morphology and ultrastructure of ischemic penumbra brain tissues were observed by hematoxylin-eosin (HE) and transmission electron microscopy (TEM). The expression levels of HIF-1 α, VEGF and β-ENaC were tested using immunohistochemistry technique, western blot and quantitative PCR analysis, respectively.
    Results: Administration of BYHW significantly decreased cerebral edema, rat neurological function scores, reduced brain infarct volume. At the same time, BYHW had protective effect on the blood-brain barrier (BBB), which improved the morphology and ultrastructure of ischemic penumbra brain tissues. BYHW treatment significantly decreased the protein and mRNA levels of HIF-1 α and VEGF compared with the model treatment. In addition, BYHW treatment significantly up-regulated the protein and mRNA levels of β-ENaC.
    Conclusions: BYHW protected against cerebral I/R injury in MCAO rats through inhibiting the activation of the HIF-1 α /VEGF pathway and stabilizing ion channel of β-ENaC in brain, indicating that BYHW shows potential for stroke treatment in acute stage.
    Mesh-Begriff(e) Animals ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Epithelial Sodium Channels/metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Infarction, Middle Cerebral Artery/drug therapy ; Infarction, Middle Cerebral Artery/metabolism ; Infarction, Middle Cerebral Artery/pathology ; Male ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Rats, Sprague-Dawley ; Reperfusion Injury/drug therapy ; Reperfusion Injury/metabolism ; Reperfusion Injury/pathology ; Stroke/drug therapy ; Stroke/metabolism ; Stroke/pathology ; Vascular Endothelial Growth Factor A/metabolism
    Chemische Substanzen Drugs, Chinese Herbal ; Epithelial Sodium Channels ; Hypoxia-Inducible Factor 1, alpha Subunit ; Neuroprotective Agents ; Vascular Endothelial Growth Factor A ; buyang huanwu ; vascular endothelial growth factor A, rat
    Sprache Englisch
    Erscheinungsdatum 2018-09-13
    Erscheinungsland Ireland
    Dokumenttyp Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2018.09.017
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Buch: Wo guo he xie yi huan guan xi de jian gou

    Wang, Xiaobo

    2014  

    Verfasserangabe Wang Xiaobo zhu
    Mesh-Begriff(e) Physician-Patient Relations ; Health Care Reform
    Schlagwörter China
    Sprache Chinesisch
    Umfang 2, 3, 192 pages
    Ausgabenhinweis Di 1 ban.
    Dokumenttyp Buch
    ISBN 9787564333836 ; 7564333839
    Datenquelle Katalog der US National Library of Medicine (NLM)

    Zusatzmaterialien

    Kategorien

  5. Artikel: Bu Yang Huan Wu decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1 α, VEGF and promotion β-ENaC expression

    Chen, Zhen-Zhen / Xin Gong / Qi Guo / Hui Zhao / Lei Wang

    Journal of ethnopharmacology. 2019 Jan. 10, v. 228

    2019  

    Abstract: Bu Yang Huan Wu Decoction (BYHW) is a famous traditional Chinese medicine (TCM) formula used ...

    Abstract Bu Yang Huan Wu Decoction (BYHW) is a famous traditional Chinese medicine (TCM) formula used in China for the treatment of cerebral ischemic stroke. But the protective effects and underlining mechanisms of BYHW remain unclear.This study was designed to investigate the protective effects and underlining signaling mechanisms of BYHW on brain tissues in a rat model of cerebral ischemic reperfusion (I/R) injury.Liquid chromatography was used to verify the composition of BYHW. The cerebral edema and infarct volume were measured by magnetic resonance imaging (MRI). The morphology and ultrastructure of ischemic penumbra brain tissues were observed by hematoxylin-eosin (HE) and transmission electron microscopy (TEM). The expression levels of HIF-1 α, VEGF and β-ENaC were tested using immunohistochemistry technique, western blot and quantitative PCR analysis, respectively.Administration of BYHW significantly decreased cerebral edema, rat neurological function scores, reduced brain infarct volume. At the same time, BYHW had protective effect on the blood-brain barrier (BBB), which improved the morphology and ultrastructure of ischemic penumbra brain tissues. BYHW treatment significantly decreased the protein and mRNA levels of HIF-1 α and VEGF compared with the model treatment. In addition, BYHW treatment significantly up-regulated the protein and mRNA levels of β-ENaC.BYHW protected against cerebral I/R injury in MCAO rats through inhibiting the activation of the HIF-1 α /VEGF pathway and stabilizing ion channel of β-ENaC in brain, indicating that BYHW shows potential for stroke treatment in acute stage.
    Schlagwörter Oriental traditional medicine ; Western blotting ; animal models ; blood-brain barrier ; brain ; chromatography ; edema ; gene expression regulation ; immunohistochemistry ; infarction ; ion channels ; magnetic resonance imaging ; messenger RNA ; protective effect ; quantitative polymerase chain reaction ; rats ; reperfusion injury ; stroke ; tissues ; transmission electron microscopy ; ultrastructure ; vascular endothelial growth factors ; China
    Sprache Englisch
    Erscheinungsverlauf 2019-0110
    Umfang p. 70-81.
    Erscheinungsort Elsevier B.V.
    Dokumenttyp Artikel
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2018.09.017
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Metabolite identification of seven active components of Huan-Nao-Yi-Cong-Fang in rat plasma using high-performance liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry.

    Wang, Minchao / Lu, Yanzhen / Liu, Jiangang / Li, Hao / Wei, Yun

    Biomedical chromatography : BMC

    2016  Band 30, Heft 2, Seite(n) 269–279

    Abstract: Huan-Nao-Yi-Cong-Fang (HNYCF) is a potential prescription in treating Alzheimer's disease. Seven ...

    Abstract Huan-Nao-Yi-Cong-Fang (HNYCF) is a potential prescription in treating Alzheimer's disease. Seven constituents [ferulic acid (FA), 2,3,5,4'-tetrahydroxystilbene-2-O-β-d-glucoside (THSG), berberine hydrochloride (BHCl), emodin, ginsenoside Rg1 (Rg1), ginsenoside Re (Re) and ginsenoside Rb1 (Rb1)] have been used as quality chemical markers of HNYCF owing to their biological significance and high contents in crude plant materials. This study explored the metabolites of the seven bioactive components in rat plasma to give useful data for further study of the action mechanism of HNYCF. LC/MS-IT-TOF was used to simultaneously characterize the metabolites of the seven components. Using the combination of MetID Solution 1.0 software and accurate mass measurements, the metabolites of HNYCF were reliably characterized. Their structures were elucidated based on the accurate MS(2) spectra and comparisons of their changes in accurate molecular masses and fragment ions with those of parent compounds. A total of five parent active compounds (BHCl, emodin, Rg1, Rb1 and Re) and 10 metabolites were found from the rat plasma 2 h after oral administration of HNYCF dosage, of which two metabolites of emodin were observed for the first time. The proposed metabolic pathways of the bioactive components in the rat plasma are helpful for further studies on the pharmacokinetics and real active compound forms of this drug.
    Mesh-Begriff(e) Administration, Oral ; Animals ; Berberine/blood ; Berberine/chemistry ; Berberine/pharmacokinetics ; Chromatography, High Pressure Liquid/methods ; Drugs, Chinese Herbal/administration & dosage ; Drugs, Chinese Herbal/chemistry ; Drugs, Chinese Herbal/pharmacokinetics ; Emodin/blood ; Emodin/chemistry ; Emodin/pharmacokinetics ; Ginsenosides/blood ; Ginsenosides/chemistry ; Ginsenosides/pharmacokinetics ; Male ; Mass Spectrometry/methods ; Rats ; Rats, Wistar
    Chemische Substanzen Drugs, Chinese Herbal ; Ginsenosides ; Berberine (0I8Y3P32UF) ; Emodin (KA46RNI6HN)
    Sprache Englisch
    Erscheinungsdatum 2016-02
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632848-9
    ISSN 1099-0801 ; 0269-3879
    ISSN (online) 1099-0801
    ISSN 0269-3879
    DOI 10.1002/bmc.3546
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.

    Wang, Hsei-Wei / Liou, Kuo-Tong / Wang, Yea-Hwey / Lu, Chung-Kuang / Lin, Yun-Lian / Lee, I-Jung / Huang, Sheng-Teng / Tsai, Yuan-Hau / Cheng, Yi-Chieh / Lin, Hung-Jui / Shen, Yuh-Chiang

    Journal of ethnopharmacology

    2011  Band 138, Heft 1, Seite(n) 22–33

    Abstract: Ethnopharmacological relevance: Bu-yang Huan-wu decoction (BHD) is a famous ...

    Abstract Ethnopharmacological relevance: Bu-yang Huan-wu decoction (BHD) is a famous traditional Chinese medicine formula that has been used clinically in Asia to treat stroke-induced disability for centuries, but the underlying neuroprotective mechanisms are not fully understood.
    Aim of the study: In this study, we aim to investigate the mechanisms of action using an integrative neurofunctional and broad genomics approach.
    Materials and methods: Male ICR mice were subjected to an acute ischemic stroke by inducing a middle cerebral ischemic/reperfusion (CI/R) injury. To examine whether BHD could extend the lifespan of mice with a stroke, we used oral administration of BHD (0.5 and 1.0g/kg) twice daily starting from 2h after ischemia and compared this with vehicle control treatments, recombinant tissue-type plasminogen activator (rt-PA, 10mg/kg, i.v.), and MK-801 (0.2mg/kg, i.p.). An integrative neurofunctional and genomic approach was performed to elucidate the underlying molecular mechanisms of BHD.
    Results: More than 80% of the mice died within 2 days after stroke induction in the vehicle control treatment group. However, the survival rates and life-spans of mice treated with BHD, rt-PA and MK-801 were significantly enhanced as compared to the vehicle-treated CI/R group in all three cases. Mice treated with BHD (1.0g/kg) showed the greatest protective effect across all groups. BHD successfully restored brain function, ameliorated the cerebral infarction, and significantly improved the neurological deficits of the mice with a stroke. BHD also reduced inflammation, oxidative stress, and apoptosis, as well as improved neurogenesis. The molecular impacts of BHD were assessed by genome-wide transcriptome analysis using brains from the CI/R mice. The results showed a total of 377 ischemia-induced probe-sets that were significantly influenced by BHD including 93 probe-sets that were commonly more abundant in BHD-treated and sham mice, and another 284 ischemia-induced probe sets that were suppressed by BHD. Mining the functional modules and genetic networks of these 377 genes revealed a significant upregulation of neuroprotective genes associated with neurogenesis (6 genes) and nervous system development (9 genes), and a significant down-regulation of destructive genes associated with the induction of inflammation (14 genes), apoptosis (15 genes), angiogenesis (11 genes) and blood coagulation (7 genes) by BHD.
    Conclusions: Our results suggested that BHD is able to protect mice against stroke and extend lifespan primarily through a significant down-regulation of genes involved in inflammation, apoptosis, angiogenesis and blood coagulation, as well as an up-regulation of genes mediating neurogenesis and nervous system development. The changes in expression after treatment with BHD are beneficial after ischemic stroke.
    Mesh-Begriff(e) Animals ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Antioxidants/pharmacology ; Antioxidants/therapeutic use ; Apoptosis/drug effects ; Apoptosis/genetics ; Astragalus Plant ; Blood Coagulation/drug effects ; Blood Coagulation/genetics ; Brain/drug effects ; Brain/physiology ; Brain Ischemia/drug therapy ; Brain Ischemia/etiology ; Brain Ischemia/genetics ; Cerebral Infarction/prevention & control ; Drugs, Chinese Herbal/pharmacology ; Drugs, Chinese Herbal/therapeutic use ; Gene Expression/drug effects ; Inflammation/drug therapy ; Inflammation/genetics ; Male ; Mice ; Mice, Inbred ICR ; Neovascularization, Physiologic/drug effects ; Neovascularization, Physiologic/genetics ; Neurogenesis/drug effects ; Neurogenesis/genetics ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Oxidative Stress/drug effects ; Oxidative Stress/genetics ; Phytotherapy ; Stroke/drug therapy ; Stroke/genetics ; Stroke/mortality ; Tissue Plasminogen Activator/pharmacology
    Chemische Substanzen Anti-Inflammatory Agents ; Antioxidants ; Drugs, Chinese Herbal ; Neuroprotective Agents ; buyang huanwu ; Tissue Plasminogen Activator (EC 3.4.21.68)
    Sprache Englisch
    Erscheinungsdatum 2011-10-31
    Erscheinungsland Ireland
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2011.06.033
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Buch: Zhong guo ren xi huan tiao wu - yi ji du ben

    Wang, Ruifeng / Cui, Yonghua

    chinese people like to dance

    (Shi yong han yu fen ji yue du cong shu ; 乙级读本)

    2010  

    Titelübersetzung Chinese people like to dance <eng.>
    Titelvarianten Zhongguoren xihuan tiaowu ; Chung-kuo-jen-hsi-huan-t'iao-wu
    Verfasserangabe Ruifeng Wang
    Serientitel Shi yong han yu fen ji yue du cong shu
    乙级读本
    Sprache Chinesisch ; Englisch
    Umfang 128 S., ill
    Verlag Beijing yu yan da xue chu ban she
    Erscheinungsort Beijing
    Dokumenttyp Buch
    Anmerkung Teilw. in chines. Schr.
    Begleitmaterial 1 CD
    ISBN 9787561925225 ; 7561925220
    Datenquelle Ehemaliges Sondersammelgebiet Küsten- und Hochseefischerei

    Zusatzmaterialien

    Kategorien

  9. Artikel: Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice

    Wang, Hsei-Wei / Liou, Kuo-Tong / Wang, Yea-Hwey / Lu, Chung-Kuang / Lin, Yun-Lian / Lee, I-Jung / Huang, Sheng-Teng / Tsai, Yuan-Hau / Cheng, Yi-Chieh / Lin, Hung-Jui / Shen, Yuh-Chiang

    Journal of ethnopharmacology. 2011 Oct. 31, v. 138, no. 1

    2011  

    Abstract: ETHNOPHARMACOLOGICAL RELEVANCE: Bu-yang Huan-wu decoction (BHD) is a famous ...

    Abstract ETHNOPHARMACOLOGICAL RELEVANCE: Bu-yang Huan-wu decoction (BHD) is a famous traditional Chinese medicine formula that has been used clinically in Asia to treat stroke-induced disability for centuries, but the underlying neuroprotective mechanisms are not fully understood. AIM OF THE STUDY: In this study, we aim to investigate the mechanisms of action using an integrative neurofunctional and broad genomics approach. MATERIALS AND METHODS: Male ICR mice were subjected to an acute ischemic stroke by inducing a middle cerebral ischemic/reperfusion (CI/R) injury. To examine whether BHD could extend the lifespan of mice with a stroke, we used oral administration of BHD (0.5 and 1.0g/kg) twice daily starting from 2h after ischemia and compared this with vehicle control treatments, recombinant tissue-type plasminogen activator (rt-PA, 10mg/kg, i.v.), and MK-801 (0.2mg/kg, i.p.). An integrative neurofunctional and genomic approach was performed to elucidate the underlying molecular mechanisms of BHD. RESULTS: More than 80% of the mice died within 2 days after stroke induction in the vehicle control treatment group. However, the survival rates and life-spans of mice treated with BHD, rt-PA and MK-801 were significantly enhanced as compared to the vehicle-treated CI/R group in all three cases. Mice treated with BHD (1.0g/kg) showed the greatest protective effect across all groups. BHD successfully restored brain function, ameliorated the cerebral infarction, and significantly improved the neurological deficits of the mice with a stroke. BHD also reduced inflammation, oxidative stress, and apoptosis, as well as improved neurogenesis. The molecular impacts of BHD were assessed by genome-wide transcriptome analysis using brains from the CI/R mice. The results showed a total of 377 ischemia-induced probe-sets that were significantly influenced by BHD including 93 probe-sets that were commonly more abundant in BHD-treated and sham mice, and another 284 ischemia-induced probe sets that were suppressed by BHD. Mining the functional modules and genetic networks of these 377 genes revealed a significant upregulation of neuroprotective genes associated with neurogenesis (6 genes) and nervous system development (9 genes), and a significant down-regulation of destructive genes associated with the induction of inflammation (14 genes), apoptosis (15 genes), angiogenesis (11 genes) and blood coagulation (7 genes) by BHD. CONCLUSIONS: Our results suggested that BHD is able to protect mice against stroke and extend lifespan primarily through a significant down-regulation of genes involved in inflammation, apoptosis, angiogenesis and blood coagulation, as well as an up-regulation of genes mediating neurogenesis and nervous system development. The changes in expression after treatment with BHD are beneficial after ischemic stroke.
    Schlagwörter angiogenesis ; apoptosis ; blood coagulation ; brain ; gene induction ; genes ; infarction ; inflammation ; longevity ; mechanism of action ; mice ; oral administration ; oxidative stress ; plasminogen activator ; protective effect ; stroke ; survival rate ; traditional medicine ; transcriptome
    Sprache Englisch
    Erscheinungsverlauf 2011-1031
    Umfang p. 22-33.
    Erscheinungsort Elsevier Ireland Ltd
    Dokumenttyp Artikel
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2011.06.033
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  10. Artikel: [Effects of bu yang huan wu decoction on astrocytes after cerebral ischemia and reperfusion].

    Lai, Zhen / Wang, Sha-yan / Geng, Xiao-yin / Deng, Chang-qing / Zhang, Ruan-zhang

    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

    2002  Band 27, Heft 10, Seite(n) 763–765

    Abstract: Objective: To study the effects of Bu Yang Huan Wu Decoction on astrocytes after cerebral ischemia ... a peak after cerebral ischemia for 15 min followed by reperfusion for 24 hours. Bu Yang Huan Wu Decoction ... by reperfusion for 48 hours, Bu Yang Huan Wu Decoction increased the expression.: Conclusion: The regulation ...

    Abstract Objective: To study the effects of Bu Yang Huan Wu Decoction on astrocytes after cerebral ischemia and reperfusion.
    Method: Cerebral ischemia model in gerbils was produced by ligating bilateral common carotid artery. The dynamic expressin of GFAP were determined by immunochemistry after cerebyal ischemia for 15 min followed by reperfusion for 24 hours and 48 hours.
    Result: GFAP positive reactions reached a peak after cerebral ischemia for 15 min followed by reperfusion for 24 hours. Bu Yang Huan Wu Decoction decreased the expression. GFAP positive reactions decreased after cerebral ischemia for 15 min followed by reperfusion for 48 hours, Bu Yang Huan Wu Decoction increased the expression.
    Conclusion: The regulation of Bu Yang Huan Wu Decoction on astrocytes after cerebral ischemia and reperfusion may be related to repairing process after cerebral ischemia.
    Mesh-Begriff(e) Animals ; Astrocytes/drug effects ; Brain Ischemia/complications ; Drugs, Chinese Herbal/isolation & purification ; Drugs, Chinese Herbal/pharmacology ; Female ; Glial Fibrillary Acidic Protein/metabolism ; Hippocampus/metabolism ; Male ; Plants, Medicinal/chemistry ; Reperfusion Injury/etiology ; Reperfusion Injury/metabolism ; Reperfusion Injury/pathology
    Chemische Substanzen Drugs, Chinese Herbal ; Glial Fibrillary Acidic Protein ; buyang huanwu
    Sprache Chinesisch
    Erscheinungsdatum 2002-10
    Erscheinungsland China
    Dokumenttyp English Abstract ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1004649-5
    ISSN 1001-5302 ; 0254-0029
    ISSN 1001-5302 ; 0254-0029
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang